Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Covered in this story
What has happened since
- ResMed is up 11.0% since this was published, 19 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on ResMed
- Stifel: $219 → $235 by Oct 2027 · Hold via Investing.com
- RBC Capital Markets: $229 → $262 by Sep 2027 · Outperform via Investing.com
- KeyBanc Capital Markets: $240 → $267 by Aug 2027 · Overweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RMD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on ResMed →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.